Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
ID: ALA5195140
Max Phase: Preclinical
Molecular Formula: C33H42N6O5S
Molecular Weight: 634.80
Associated Items:
ID: ALA5195140
Max Phase: Preclinical
Molecular Formula: C33H42N6O5S
Molecular Weight: 634.80
Associated Items:
Canonical SMILES: CC(C)(C)NC(=O)NC1CCN(C(=O)[C@H](Cc2cccc(C(=N)N)c2)NS(=O)(=O)c2cccc(-c3ccc(CO)cc3)c2)CC1
Standard InChI: InChI=1S/C33H42N6O5S/c1-33(2,3)37-32(42)36-27-14-16-39(17-15-27)31(41)29(19-23-6-4-8-26(18-23)30(34)35)38-45(43,44)28-9-5-7-25(20-28)24-12-10-22(21-40)11-13-24/h4-13,18,20,27,29,38,40H,14-17,19,21H2,1-3H3,(H3,34,35)(H2,36,37,42)/t29-/m0/s1
Standard InChI Key: GEFPGKFCGQRFNV-LJAQVGFWSA-N
Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
Natural Product: No | Oral: No | Chemical Probe: No | Parenteral: No |
Molecule Type: | Topical: No | First In Class: No | Black Box: No |
Chirality: No | Availability: No | Prodrug: No |
MESH ID | MESH Heading | EFO IDs | EFO Terms | Max Phase for Indication | References |
---|
Mechanism of Action | Action Type | target ID | Target Name | Target Type | Target Organism | Binding Site Name | References |
---|
Molecular Weight: 634.80 | Molecular Weight (Monoisotopic): 634.2937 | AlogP: 3.11 | #Rotatable Bonds: 10 |
Polar Surface Area: 177.71 | Molecular Species: BASE | HBA: 6 | HBD: 6 |
#RO5 Violations: 2 | HBA (Lipinski): 11 | HBD (Lipinski): 7 | #RO5 Violations (Lipinski): 3 |
CX Acidic pKa: 10.04 | CX Basic pKa: 11.47 | CX LogP: 1.54 | CX LogD: -0.37 |
Aromatic Rings: 3 | Heavy Atoms: 45 | QED Weighted: 0.15 | Np Likeness Score: -1.02 |
1. Pilgram O, Keils A, Benary GE, Müller J, Merkl S, Ngaha S, Huber S, Chevillard F, Harbig A, Magdolen V, Heine A, Böttcher-Friebertshäuser E, Steinmetzer T.. (2022) Improving the selectivity of 3-amidinophenylalanine-derived matriptase inhibitors., 238 [PMID:35635944] [10.1016/j.ejmech.2022.114437] |
Source(1):